7 myths about methotrexate therapy for RA
DOCTORS need to address methotrexate’s image problem among patients with rheumatoid arthritis, specialists say.
Rheumatology researchers from the University of Sydney say misconceptions about methotrexate toxicity are rife and could even result in nocebo effects.
Here are seven myths they say need busting:
A single dose for chemotherapy regimens can be higher than 500mg/m2, yet for rheumatic disease the doses are considerably lower,